Morie A. Gertz

Research interests

Publications

• Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

  Blood Reviews · 2019 · 10.1016/j.blre.2019.100648

• Systemic immunoglobulin light chain amyloidosis

  Nature Reviews Disease Primers · 2018 · 10.1038/s41572-018-0034-3

• Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716793

• Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

  Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.06.033

• Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

  Journal of the American College of Cardiology · 2015 · 10.1016/j.jacc.2015.09.075

• Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

  Mayo Clinic Proceedings · 2013 · 10.1016/j.mayocp.2013.01.019

• Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

  Leukemia · 2013 · https://doi.org/10.1038/leu.2013.313

• New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.37.7614

• Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.5724

• Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

  Blood · 2011 · 10.1182/blood-2010-10-299529

• Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

  Leukemia · 2011 · https://doi.org/10.1038/leu.2011.196

• Amyloidosis: Pathogenesis and New Therapeutic Options

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.32.2271

• Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis

  JACC. Cardiovascular imaging · 2010 · 10.1016/j.jcmg.2009.09.023

• Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

  Mayo Clinic Proceedings · 2009 · 10.4065/mcp.2009.0603

• International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

  Leukemia · 2008 · 10.1038/leu.2008.307

• Improved survival in multiple myeloma and the impact of novel therapies

  Blood · 2007 · 10.1182/blood-2007-10-116129

• International uniform response criteria for multiple myeloma

  Leukemia · 2006 · 10.1038/sj.leu.2404284

• Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

  American Journal of Hematology · 2005 · 10.1002/ajh.20381

• Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

  Blood · 2005 · 10.1182/blood-2005-07-2817

• Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

  Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.03.029

• POEMS syndrome: definitions and long-term outcome

  Blood · 2003 · 10.1182/blood-2002-07-2299

• Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

  Mayo Clinic Proceedings · 2003 · 10.4065/78.1.21

• Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.02.116

• CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

  British Journal of Haematology · 1998 · 10.1046/j.1365-2141.1998.00930.x

• A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

  New England Journal of Medicine · 1997 · 10.1056/nejm199704243361702

Current projects

No projects listed.